Target intelligence / Profile preview

DNAJC17 pseudogene 1 (DNAJC17P1)

Target: DNAJC17P1
Molecular classification: Other (Pseudogene)

Overview

DNAJC17 pseudogene 1 (DNAJC17P1) is a genomic DNA sequence classified as a pseudogene of the DNAJC17 gene family. Pseudogenes are genetic elements that arise from duplication or retrotransposition of functional genes but have lost their ability to code for proteins or exert biological activity due to accumulated mutations. DNAJC17P1 does not perform known biological functions and is not considered a therapeutic target, receptor, enzyme, or drug-interacting protein[3].

Other names: DNAJC17P1DNAJC17 pseudogene 1

Beyond the preview

Go deeper on DNAJC17 pseudogene 1 (DNAJC17P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNAJC17 pseudogene 1 (DNAJC17P1).

Explore the full profile